Short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, exhibit broad therapeutic potential across multiple disease categories, including neurodegenerative and demyelinating conditions. They primarily act through mechanisms like G-protein-coupled receptor (GPCR) activation (e.g., GPR41/43/109A), histone deacetylase (HDAC) inhibition, anti-inflammatory effects (e.g., Treg promotion, NF-κB suppression), and metabolic regulation (e.g., AMPK activation for lipid/glucose homeostasis). […]
Short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate, emerge as promising therapeutic agents in Alzheimer’s disease (AD). Short-chain fatty acids are produced by gut microbiota fermentation of dietary fibers. These SCFAs play a complex role in Alzheimer’s disease (AD) through the microbiota-gut-brain axis. AD patients exhibit gut dysbiosis with reduced SCFA-producing bacteria (e.g., Faecalibacterium […]
Gut dysbiosis, marked by diminished microbial diversity and imbalanced bacterial composition, is a hallmark of Alzheimer’s disease (AD) AD often emerges in prodromal stages like mild cognitive impairment (MCI) and contributes to pathogenesis through the microbiota-gut-brain axis. AD patients show consistent reductions in short-chain fatty acid (SCFA)-producing taxa and enrichments in pro-inflammatory genera, correlating with […]
Gut dysbiosis is characterized by reduced microbial diversity and shifts in bacterial composition. It is a prominent feature in Parkinson’s disease (PD), often preceding motor symptoms by years and contributing to disease initiation and progression via the microbiota-gut-brain axis. PD patients exhibit consistent alterations, including depletion of short-chain fatty acid (SCFA)-producing bacteria and enrichment of […]
The connection between our gut microbiome and mental health is a reality. Depressive disorder (like major depression), generalized anxiety disorder, bipolar disorder, and eating disorders (such as anorexia nervosa or bulimia) are all linked to the gut microbiome—the trillions of bacteria and other microbes living in our intestines. These connections happen mainly through the gut-brain […]
Let us look at using apple cider vinegar to increase stomach acid and reduce Candida for a client case with Candida overgrowth, leaky gut and long-term PPI, corticosteroid, antibiotic, and thyroid medication use. Should our client try 1 tablespoon of apple cider vinegar (ACV) diluted in 8 ounces of water after meals as a potential […]
Below, I’ll provide additional details on the link between gut dysbiosis, acid reflux (GERD), and asthma, focusing on recent research (2023–2025) on the gut-lung axis and practical strategies for managing GERD in the context of dysbiosis, tailored to a client’s situation (Candida overgrowth, leaky gut, long-term PPI, corticosteroid, antibiotic, and thyroid medication use). I’ve incorporated […]
Could there be a link between gut dysbiosis, GERD and asthma? Yes. There is a significant and increasingly recognized link between gut dysbiosis, acid reflux (gastroesophageal reflux disease, GERD), and asthma. These conditions can interact through complex physiological mechanisms, including inflammation, immune dysregulation, and the gut-lung axis. Below is a concise explanation of their connections, […]